Data completeness
4/8 — Partial
METAXALONE (metaxalone) by Pfizer is rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions has not been established, but may be due to general cns depression. First approved in 2015.
Drug data last refreshed 12h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Metaxalone is an oral muscle relaxant approved for relief of discomfort associated with acute, painful musculoskeletal conditions, used as adjunct to rest and physical therapy. Its mechanism is believed to involve general CNS depression rather than direct muscle action. It is a small-molecule tablet indicated for acute musculoskeletal pain management.
$0.3MPart D
Peak16.8 years to LOEPeak-stage product with minimal Medicare claims (1,871 in 2023) indicates modest commercial opportunity with stable but limited market footprint.
Mechanism of Action
rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions has not been established, but may be due to general CNS depression. Metaxalone has no direct action on the contractile mechanism of striated muscle, the motor end plate,…
Pharmacologic Class:
Muscle Relaxant
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Metaxalone offers limited career visibility with zero linked job openings, indicating a mature, small-market product with minimal hiring momentum. Career value derives from steady-state brand management and routine field execution rather than growth opportunity.
Brand Manager
Worked on METAXALONE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.